- BBC News - Cancer cell enzymes shown to act as 'good cops' http://t.co/DHX45749NS
- Biowebspin | Events - Biowebspin http://t.co/Z7jC3x16bn via @
- Glasgow scientist wins award for disease detection | Herald Scotland http://t.co/aVzVgWvHmr via @
- Richard Smith: Stratified, personalised, or precision medicine http://t.co/BpLzVvzjt2
- New treatments see blood cancer survival rates up - Health - http://t.co/ss8qL7GgxR: http://t.co/gG0b8Ux6zq
- Antibiotics linked to longer life | Herald Scotland http://t.co/4tet0r5J2g via @
- BBC News - What kind of NHS can Britain afford? http://t.co/d43xAsiqBE
- Comment: Scotland needs free cancer drug access - News - http://t.co/ss8qL7GgxR: http://t.co/fDnlxb4L5X
- BBC News - Scots NHS alert line taking calls from rest of UK http://t.co/w45PdO9NQI
- Scientists hope chemicals found in sea could pave way for treatments | Herald Scotland http://t.co/o95viBbNev via @
- Scientists use skin to create stem cells - Health - http://t.co/5KO1Mcyue1: http://t.co/La1R61GmMW
- RT @ : RT @ : Remember you can catch today's #EIE13 video pitches here: http://t.co/f3m0YS3kWU
- http://t.co/XMwu1VaOKc
- So does the Myriad approach constrain and free innovation in genomics? http://t.co/D9jamXOUB3
- Myriad Genetics stock rises on Angelina Jolie surgery http://t.co/PnK3omGviY via @
Scottish Centre For Regenerative Medicine
The goal of the Scottish Centre for Regenerative Medicine is to generate a new class of medicines that promote repair and which, taken together with conventional medicines, will enable physicians to both treat cause and reverse damage. To enable this, the Scottish Government and the University of Edinburgh have jointly invested over £600m in a new Centre purpose built for stem cell biology and medicine. In addition to 3,500 sqm of laboratory space and state of the art tissue culture facilities, the building contains imaging and small animal surgery facilities, a 7 room cGMP facility suitable for ATMP work alongside an academic cell therapy unit.
The centre brings together two scientific groups – stem cell biologists of the internationally-leading Institute of Stem Cell Research and clinical academics working on regeneration in liver, blood and brain – with scientists expert in the derivation and manufacture cells at cGMP grade working with the Scottish National Blood Transfusion Service and a not-for-profit company Roslin Cells.
The excellence of this innovative development has already been recognised by the award of MRC Centre status. The resulting community, already more than 150 strong and growing is uniquely placed to collaborate with industry in the discovery and delivery of novel therapies in regenerative medicine.
